Walleye Trading’s Xeris Biopharma Holdings XERS Stock Holding History

Walleye Trading’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-43,427	Closed	-$85K	–	4662
2020 Q1	$85K	Buy	+43,427	New	+$187K	﹤0.01%	3204

Other funds holding XERS

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Walleye Trading's XERS Position: Q2 2020 in Review

Walleye Trading sold out of Xeris Biopharma Holdings (XERS) in Q2 2020, closing a stake of 43,427 shares — an estimated $85K sold.

Walleye Trading first reported a position in XERS in Q1 2020 and held it in 1 quarter. The position peaked at $85K in Q1 2020. 86 funds tracked by Wall St. Rank hold XERS as of Q2 2020.

Walleye Trading reported no remaining Xeris Biopharma Holdings position as of Q2 2020 after selling out during the quarter.
Walleye Trading sold 43,427 Xeris Biopharma Holdings shares in Q2 2020, an estimated $85K.
Walleye Trading first reported a position in Xeris Biopharma Holdings in Q1 2020 and held it in 1 quarter.
Walleye Trading's Xeris Biopharma Holdings position peaked at $85K in Q1 2020.
86 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.